Further study showed its low expression results from TUSC3 promoter hypermethylation and the methylation status of the TUSC3 promoter has a significant and independent influence on progression free and overall survival for ovarian cancer patients [25]. This evidence concerns the gene TUSC3 and ovarian carcinoma.